AI-powered egg quality assessment uses deep learning to score eggs from lab images, giving faster, clearer guidance for IVF. Backed by fresh funding, Future Fertility’s tools (VIOLET, MAGENTA, ROSE) help clinics and patients set expectations, plan cycles, and make better decisions. The models are trained on 650,000 images and used in 300+ clinics across 35 countries. IVF is stressful and expensive. Egg quality is one of the biggest factors in success, yet most patients never get an objective score. That is starting to change. With AI-powered egg quality assessment, clinics can turn a quick image of an oocyte into data that informs care and improves counseling.

What is AI-powered egg quality assessment?

AI-powered egg quality assessment uses deep learning to analyze images of eggs (oocytes) taken in the IVF lab. The system studies patterns that are hard for the human eye to judge the same way every time. It then returns a score that helps gauge likely developmental potential. Future Fertility has built three tools for key moments: – VIOLET for egg freezing decisions – MAGENTA for IVF cycle planning – ROSE for egg donation programs These models are trained and validated on more than 650,000 oocyte images. They are already deployed in over 300 clinics across 35 countries. The aim is simple: give clinicians and patients objective, clinically studied information they can use right away.

Why clarity on egg quality matters

Better counseling and realistic expectations

– Patients want to know their chances. Studies show many do not understand likely outcomes and may stop treatment early. – A clear egg quality score supports honest, calm discussions about next steps and total number of cycles to consider.

Smarter protocol and cycle planning

– Scores can guide fertilization strategy and lab workflow. – Teams can match resources to likely embryo development and plan timelines more efficiently.

Reducing drop-off, improving cumulative success

– IVF success often rises over multiple cycles. – Early, objective guidance can help patients commit to a plan that reflects cumulative outcomes, not a single attempt.

Inside the Future Fertility platform

Tools and where they fit

– VIOLET: Helps people considering egg freezing weigh timing and expected return on eggs frozen today versus waiting. – MAGENTA: Supports IVF decisions from retrieval to embryo selection steps, aiming to improve downstream choices. – ROSE: Assists donor programs with a consistent, data-driven view of egg quality. In the United States, ROSE is available under an FDA 513(g) determination.

Evidence and validation

– The company reports seven peer-reviewed papers across Human Reproduction, Reproductive BioMedicine Online, Fertility & Sterility, and Scientific Reports. – More than 70 scientific abstracts have been presented with partner clinics worldwide. – External networks, including IVI RMA and Eugin Group in Europe and Latin America, FertGroup Medicina Reproductiva in Brazil, and Kato Ladies Clinic in Japan, have adopted the approach, signaling real-world demand.

Global growth and the regulatory path

New funding

Future Fertility closed a US$4.1 million Series A round led by M Ventures (the corporate venture arm of Merck KGaA, Darmstadt, Germany) and Whitecap Venture Partners. New investors include Sandpiper Ventures, Gaingels, and Jolt VC. The funds will push expansion in Asia-Pacific and support U.S. market entry, including planned FDA 510(k) submissions for additional products.

Scale and partnerships

The platform is rolling out through leading networks and independent clinics. As adoption spreads, shared datasets and standard workflows can improve consistency, benchmarking, and continuous model refinement.

What clinics and patients can expect now

Clinic workflows

– Capture standard oocyte images during routine lab steps. – Receive quality scores and visual markers through a secure dashboard. – Integrate results into counseling, consent, and cycle planning. – Access training and support to keep lab routines efficient.

Patient experience

– See clear visuals and objective scores that explain likely paths. – Discuss options like continuing a cycle, planning another retrieval, or adjusting strategy. – Walk away with a plan that reflects both data and personal goals.

Practical tips to use AI insights during IVF

For patients

– Ask if your clinic uses AI-powered egg quality assessment and how results guide decisions. – Request your score explanation in plain language and how it affects next steps. – Discuss how the score fits with your age, medical history, and embryo development so far. – Plan for cumulative success: talk about total cycles, not just the current one.

For clinics

– Start with a pilot: one cohort, clear endpoints, and defined counseling scripts. – Train staff on image capture standards to reduce variability. – Embed scores into case conferences and patient consult templates. – Track outcomes longitudinally to measure impact on drop-off and cumulative live birth rates.

Risks, limits, and responsible use

– AI supports decisions; it does not replace clinician judgment. – Scores reflect probabilities, not guarantees. – Image quality, lab protocols, and patient factors still matter a lot. – Keep informed consent clear: explain what the score means and what it does not.

The bottom line on AI-powered egg quality assessment

With stronger data and simple lab images, AI-powered egg quality assessment can cut guesswork and support smarter IVF choices. Backed by peer-reviewed studies, global clinic use, and new funding for U.S. and APAC growth, it offers earlier clarity that may boost success and trust—exactly what patients and care teams need.

(Source: https://www.femtechworld.co.uk/news/fertility-news/future-fertility-raises-series-a-financing-to-scale-ai-tools-redefining-fertility-care-worldwide-ffert25/)

For more news: Click Here

FAQ